SODIUM 4-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1-PIPERAZINECARBODITHIOATE
UNII V8JRB5C5CM

Substance Identification & Data

This profile provides standardized clinical and technical data for Sodium 4-(3-methyl-1,2,4-thiadiazol-5-yl)-1-piperazinecarbodithioate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V8JRB5C5CM.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 69389-05-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

V8JRB5C5CM

CAS Registry Number

69389-05-5

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

SODIUM 4-(3-METHYL-1,2,4-THIADIAZOL-5-YL)-1-PIPERAZINECARBODITHIOATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C8H11N4S3.Na

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

JCLQYCSHSFILAG-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

23690464

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

Cc1nc(N2CCN(CC2)C(=S)[S-])sn1.[Na+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Sodium 4-(3-methyl-1,2,4-thiadiazol-5-yl)-1-piperazinecarbodithioate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.